Data as of Dec 19
| +1.69 / +1.00%|
The 20 analysts offering 12-month price forecasts for Amgen have a median target of 176.51, with a high estimate of 196.00 and a low estimate of 130.00. The median estimate represents a +3.73% increase from the last price of 170.17.
The current consensus among 24 polled investment analysts is to Buy stock in Amgen. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.